Year: 2021

Zai-Lab-Limited-4

Zai Lab and Entasis Therapeutics Announce Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK Trial

SUL-DUR first to achieve statistical non-inferiority in 28-day all-cause mortality in carbapenem-resistant Acinetobacter (CRAB) patients Statistically significant difference in clinical...

SharpLink-Gaming-Ltd-

SportsHub Games Network Integrates SharpLink’s C4 Sports Betting Conversion Technology with NFC High Stakes and Fanball Daily Fantasy Sports Gaming Sites

Entertaining Hundreds of Thousands of Fantasy Sports Fans Annually, SportsHub Sites Demonstrating that Fantasy Games Are Important Gateway to Sports...

news_6

D&D Pharmatech Raises $51M in Series C Financing to Advance Potential Disease-Modifying Treatments for Neurodegenerative, Fibrotic, and Metabolic Diseases

Proceeds to Support Advancement of Phase 2 Clinical Trials Financing Led by Praxis Capital GYEONGGI-DO, Korea & GAITHERSBURG, Md.--(BUSINESS WIRE)--D&D...